All Companies
JNJCongressional Stock Trades
Johnson & Johnson
Pharmaceutical Preparations
Congressional stock trades in Johnson & Johnson (JNJ) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
53
Politicians Trading
21
Last Traded
Aug 27, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Ro KhannaD | Sep 4, 2026 | Aug 7, 2026 | Sell | $1,001 - $15,000 | +4.15% |
| Julie JohnsonD | Jan 15, 2026 | Dec 18, 2025 | Sell | $1,001 - $15,000 | +29.61% |
| Julie JohnsonD | Dec 11, 2025 | Nov 13, 2025 | Sell | $1,001 - $15,000 | +38.28% |
| Jared MoskowitzD | Nov 22, 2025 | Oct 10, 2025 | Sell | $1,001 - $15,000 | +41.56% |
| Jared MoskowitzD | Nov 22, 2025 | Oct 10, 2025 | Sell | $1,001 - $15,000 | +41.56% |
| Val T. HoyleD | Oct 10, 2025 | Sep 23, 2025 | Sell | $1,001 - $15,000 | +52.90% |
| Kelly MorrisonD | Sep 11, 2025 | Aug 19, 2025 | Sell | $1,001 - $15,000 | +51.85% |
| Julie JohnsonD | Sep 11, 2025 | Aug 14, 2025 | Sell | $1,001 - $15,000 | +54.53% |
| Josh GottheimerD | May 14, 2025 | Apr 9, 2025 | Sell | $1,001 - $15,000 | +78.84% |
| Julie JohnsonD | May 14, 2025 | Apr 1, 2025 | Sell | $1,001 - $15,000 | +76.18% |
| Gilbert Ray Cisneros, Jr.D | May 6, 2025 | Apr 29, 2025 | Sell | $1,001 - $15,000 | +73.17% |
| George WhitesidesD | Apr 23, 2025 | Mar 24, 2025 | Sell | $100,001 - $250,000 | +65.34% |
| Josh GottheimerD | Apr 10, 2025 | Mar 7, 2025 | Sell | $1,001 - $15,000 | +61.97% |
| Gilbert Ray Cisneros, Jr.D | Feb 11, 2025 | Jan 24, 2025 | Sell | $1,001 - $15,000 | +83.89% |
Price History
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.